Compare deBridge (DBR) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
deBridge vs Enzyme — how do they compare? deBridge trades at Rp293.93 (market cap Rp563,46M, Rp94,19M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: deBridge is far larger — about 4.2× Enzyme's market cap, and deBridge's supply is capped (1,9B / 10B DBR (20%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold deBridge for 9 Days and Enzyme for 28 Days on average.
| DBR | MLN | |
|---|---|---|
Market Cap | Rp563,46M | Rp134,13M |
Volume (24h) | Rp94,19M | Rp104,56M |
Circulating Supply | 1,9B / 10B DBR (20%) | 3,3M MLN |
Typical Hold Time | 9 Days | 28 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
deBridge (DBR) trades at Rp293.37 with a market cap of Rp563.46M, showing a bullish technical signal from moving averages but neutral oscillators. The token has a circulating supply of 1.9M out of 10M (20% circulation rate), with key resistance at Rp299 and support at Rp292. Recent on-chain data indicates a short hold time of 9 days, suggesting active trading. No major protocol updates or ecosystem news were reported in the last week (CoinGecko, April 2025).
Overall outlook is cautiously optimistic due to strong technical momentum, but high RSI levels signal overbought conditions. Key opportunities include potential breakout above Rp299 resistance, while risks involve low liquidity, regulatory uncertainty in crypto markets, and volatility from thin order books. Investors should monitor exchange volume trends and broader crypto sentiment.
Enzyme (MLN) shows a market cap of Rp134,13M with a circulating supply of 3,3jt tokens. The asset's price data is currently unavailable, but the hold time of 28 days suggests moderate trader retention. Recent news on ETF inflows may indirectly affect crypto sentiment, though no direct protocol updates are noted. Trading volumes and network activity metrics require verification from live crypto data sources for a complete picture.
Outlook: Enzyme faces typical crypto volatility risks with limited recent fundamental developments. Opportunities may arise from broader market trends, but investors should monitor liquidity and regulatory shifts closely. Major risks include low market cap susceptibility to manipulation and absence of max supply clarity.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About deBridge
deBridge is the internet of liquidity for DeFi, enabling real-time transfer of assets and data across chains. By removing the risks of liquidity pools, it powers secure cross-chain interactions with deep liquidity, tight spreads, and guaranteed rates.
Read more on DBR →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
